Dinamite Dipharma

Dipharma is a prominent European contract development and manufacturing organization (CDMO) specializing in the synthesis of active pharmaceutical ingredients (APIs) and advanced intermediates. The company was significantly strengthened by the acquisition of Dinamite, which brought specialized expertise in hazardous chemistry, nitration, and high-pressure hydrogenation. Dipharma offers a full range of services from early-stage process R&D to large-scale commercial manufacturing under cGMP conditions. With a global presence and manufacturing sites in Italy and the United States, the company serves both innovator and generic pharmaceutical companies. Their business model focuses on complex chemical processes and a robust portfolio of generic APIs across diverse therapeutic areas.